Latest radiation therapy Stories
Cianna Medical, Inc.: Researchers from 12 sites report favorably low recurrence rates and minimal toxicities. CHICAGO (PRWEB) May 02, 2013 Strut-based breast brachytherapy – a form of radiation therapy for early-stage breast cancer – has been shown to be a well-tolerated, effective treatment, according to a scientific poster presentation at the 2013 annual meeting of the American Society of Breast Surgeons (ASBrS) in Chicago, May 1-5, 2013. The...
Findings Demonstrate Utility of Oncotype DX® to Guide Radiation Treatment Decision for DCIS Patients and Support Expanded Access and Reimbursement REDWOOD CITY, Calif. and PHILADELPHIA, May 2, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) and the ECOG-ACRIN Cancer Research Group announced today that the Journal of the National Cancer Institute (JNCI) published positive results from their clinical validation study of the Oncotype DX® DCIS Score in patients with ductal...
Technology advancements paired with new tools allow neurosurgeons to resect deep brain tumors once deemed inoperable CHICAGO, May 1, 2013 /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America (CTCA) at Midwestern Regional Medical Center (Midwestern) is among the first hospitals in the country to offer a new minimally invasive surgery for patients with deep subcortical tumors and cysts. The new approach integrates several advancements in neurosurgery, allowing doctors to...
'This study confirms that VEGF is not a path forward to tackling this disease' The well-studied protein VEGF does not appear to have any prognostic or predictive value for men with locally advanced prostate cancer, researchers from the Department of Radiation Oncology at Thomas Jefferson University Hospital and other institutions found in a retrospective study published online April 25 in the journal BMC Radiation Oncology. VEGF, or vascular endothelial growth factor, induces blood...
128 Patient MuGard Study Underscores the Powerful Clinical Impact MuGard Provides Cancer Patients Suffering with Oral Mucositis DALLAS and NEW YORK, April 29, 2013 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, announced that Carrie Daly, MS, RN, APN, AOCN of Rush University Medical Center presented data from a MuGard study, performed by the Institution, at last week's Oncology Nursing Society Annual Congress in Washington, DC....
Oncology Departments in North Middlesex and Poole Acquire Final Two TrueBeam Systems Made Available Under NHS Supply Chain Initiative CRAWLEY, U.K., April 29, 2013 /PRNewswire/ -- Hospitals in London and Dorset have acquired the final two of ten advanced Varian Medical Systems (NYSE: VAR) radiotherapy treatment machines offered as part of an innovative government program to roll out the most modern cancer treatments for patients in the UK's public hospitals. North Middlesex...
Dennis R. HIll MD, Radiation Oncologist at the Alta Bates Summit Medical Center in Oakland, CA discusses the latest in prostate cancer treatments. Oakland, CA (PRWEB) April 27, 2013 Dennis R. Hill MD, Radiation Oncologist at the Alta Bates Summit Medical Center in Oakland, CA, who specializes in HDR Prostate Brachytherapy, a prostate cancer treatment option with less risk of side effects than external beam radiation methods, discusses a newer treatment now available, called the Calypso...
Novel approach using Listeria bacteria shows promise against a deadly disease BRONX, N.Y., April 24, 2013 /PRNewswire-USNewswire/-- Researchers at Albert Einstein College of Medicine of Yeshiva University have developed a therapy for pancreatic cancer that uses Listeria bacteria to selectively infect tumor cells and deliver radioisotopes into them. The experimental treatment dramatically decreased the number of metastases (cancers that have spread to other parts of the body) in a...
LONDON, ON, April 24, 2013 /PRNewswire/ - A world first procedure performed at London Health Sciences Center (LHSC) and facilitated by research at Lawson Health Research Institute (Lawson) provides a new minimally invasive treatment option for patients with localized prostate cancer. The treatment - transurethral magnetic resonance (MR) guided ultrasound ablation for prostate cancer - utilizes a new ablation device that uses thermal ultrasound therapy with real-time MR image...
GLENWOOD, Ill., April 23, 2013 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, will release financial results for the fiscal second quarter 2013 after the market close on Monday, May 6, 2013. The Company will host a conference call for investors on Tuesday, May 7, 2013, at 9:00 a.m. Central Time (10 a.m. Eastern...
